DUBLIN--(BUSINESS WIRE)--The "Drug Delivery Systems Market to 2027- Global Analysis and Forecasts by Route of Administration; Distribution Channel; Application and Geography" report has been added to ResearchAndMarkets.com's offering.
The global drug delivery systems market is expected to reach US$ 2,302.2 Bn in 2027 from US$ 1,243.1 Bn in 2018. The market is estimated to grow with a CAGR of 7.2% from 2019-2027.
The market is driven by the factors such as, rising incidence of chronic diseases, growing demand for non-invasive drug delivery devices, increasing R&D expenditures in and pharmaceutical and medical device companies. However, the factors restraining the market growth are high cost involved in development of drug delivery devices and product recalls.
With the improvements in medical devices and certain transdermal delivery technologies, the non-invasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. The Non-Invasive Drug Delivery Systems encompasses the broad field of non-invasive drug delivery systems which includes drug delivery via topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, as well as delivery via alveolar membrane from inhaled medication. Patient compliance has been found to be much higher when administrated by non-invasive routes due to decreased pain involved in drug delivery and therefore these techniques are considered to be a preferred mode of drug delivery.
The traditional drug delivery techniques, like intramuscular, intravenous, oral and rectal drug administration are not suitable to certain patient populations. The non-invasive methods of drug delivery reduces dosing frequency and simplifies dosing schedules. Moreover, non-invasive drug delivery system can significantly reduce the cost of clinical use because of self-administration of the drugs by the patients. The manufacturing cost may also be less for non-invasive dosage forms as compared to injections in many cases.
For instance, inhaled insulin appears to be a non-invasive, well-tolerated and liked modality of treatment of diabetes. In 2014, MannKind Corporation developed Afrezza (insulin human) inhalation powder which was approved by FDA. Thus, due to advantages offered by non-invasive drug delivery devices, the drug delivery market is expected to witness growth during the forecast period.
Global drug delivery systems market, based on the route of administration was segmented into oral, transmucosal, injectable, topical, implantable, and ocular. Oral drug delivery system segment led the market for drug delivery systems market in 2018, owing to its ease of administration and increasing demand by the patient population for various therapeutic areas.
Based on the distribution channels, the drug delivery systems market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies held the major share owing to the availability of larger range of medications required for the treatment of patient population for various medical conditions.
On the basis of application, the market is segmented into hospital & clinics, home care settings, and others. The hospitals and clinics segment held the major share in 2018. This is primarily attributed to the significant number of patient visits to hospitals and the requirement of large volumes of drugs and their respective delivery devices to fulfil to the demand of the large patient population.
Key Topics Covered:
1.1 Scope Of The Study
1.2 Report Guidance
1.3 Market Segmentation
2. Global Drug Delivery Systems Market - Key Takeaways
3. Research Methodology
4. Global Drug Delivery Systems- Market Landscape
4.2 Pest Analysis
5. Drug Delivery Systems Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Incidence Of Chronic Diseases
5.1.2 Growing Demand For Non Invasive Drug Delivery Devices
5.1.3 Increasing R&D Expenditures In Pharmaceutical And Medical Device Companies
5.2 Key Market Restraints
5.2.1 High Cost Involved In Development Of Drug Delivery Devices
5.2.2 Product Recalls
5.3 Key Market Opportunities
5.3.1 Increasing Patient Compliance
5.4 Future Trends
5.4.1 Growing New Innovations In Drug Delivery Technology
5.5 Impact Analysis
6. Drug Delivery Systems Market - Global Analysis
6.1 Global Drug Delivery Systems Market Revenue Forecasts And Analysis
6.2 Global Drug Delivery Systems Market, By Geography - Forecasts And Analysis
6.3 Performance Of Prominent Players
6.3.3 Glaxosmithkline Plc.
6.3.4 Novartis Ag
7. Drug Delivery Systems Market - Global Regulatory Scenario
8. Drug Delivery Systems Market Analysis And Forecasts To 2027 - Route Of Administration
8.2 Route Of Administration Market Revenue And Forecasts Analysis (US$ Mn)
8.3 Oral Drug Delivery Market
8.3.2 Oral Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
8.3.3 Solid Oral Drugs Market
8.3.4 Liquid Oral Drugs Market
8.3.5 Semi-Solid Oral Drugs Market
8.4 Transmucosal Drug Delivery Market
8.4.2 Transmucosal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
8.4.3 Pulmonary Drug Delivery Market
220.127.116.11 Pulmonary Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
18.104.22.168 Pulmonary Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
22.214.171.124 In-Metered Dose Inhalers Market
126.96.36.199 Dry Powder Inhalers Market
188.8.131.52 Nebulizers Market
8.4.4 Nasal Drug Delivery Market
184.108.40.206 Nasal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
220.127.116.11 Nasal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)
18.104.22.168 Nasal Spray Market
22.214.171.124 Nasal Drops Market
126.96.36.199 Nasal Gel Market
8.4.5 Buccal Drug Delivery Market
8.4.6 Sublingual Drug Delivery Market
8.4.7 Rectal Transmucosal Drug Delivery Market
8.4.8 Vaginal Transmucosal Drug Delivery Market
8.5 Topical Drug Delivery Market
8.5.2 Topical Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
8.5.3 Semi-Solid Topical Drug Delivery Formulations Market
8.5.4 Liquid Topical Drug Delivery Formulations Market
8.5.5 Solid Topical Drug Delivery Formulations Market
8.5.6 Transdermal Patches Market
8.5.7 Transdermal Gels Market
8.5.8 Others Market
8.6 Injectable Drug Delivery Market
8.6.2 Injectable Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
8.6.3 Conventional Injection Devices Market
8.6.4 Self-Injection Devices Market
188.8.131.52 Self-Injection Devices Market Revenue And Forecast To 2027 (US$ Mn)
184.108.40.206 Self-Injection Devices Market Revenue And Forecasts To 2027 (US$ Mn)
220.127.116.11 Needle Free Injectors Market
18.104.22.168 Pen Injectors Market
22.214.171.124 Wearable Injectors Market
8.7 Implantable Drug Delivery Market
8.7.2 Implantable Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
8.7.3 Active Implantable Market
8.7.4 Passive Implantable Market
8.8 Ocular Drug Delivery Market
8.8.2 Ocular Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)
8.8.3 Eye Drops And Sprays Market
8.8.4 Gels & Ointments Market
8.8.5 Ocular Inserts Market
8.8.6 Drug Coated Contact Lens Market
9. Global Drug Delivery Systems Market Analysis - By Distribution Channel
9.2 Global Drug Delivery Systems Market, By Distribution Channel 2018 & 2027 (%)
9.3 Hospital Pharmacies Market
9.4 Retail Pharmacies Market
9.5 Online Pharmacies Market
10. Global Drug Delivery Systems Market Analysis - By Application
10.2 Global Drug Delivery Systems Market, By Application 2018 & 2027 (%)
10.3 Homecare Settings Market
10.4 Hospitals & Clinics Market
10.5 Others Market
- BD (Becton Dickinson & Company)
- Boston Scientific Corporation
- Novo Nordisk A/S
- Bausch Health Companies Inc.
- Baxter International, Inc.
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
- Terumo Corporation
For more information about this report visit https://www.researchandmarkets.com/r/h34qxq